KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Hologic (HOLX) Shares Repurchased (2016 - 2025)

Hologic (HOLX) has disclosed Shares Repurchased for 10 consecutive years, with $35.6 million as the latest value for Q2 2025.

Quarterly Shares Repurchased fell 64.4% to $35.6 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $235.6 million through Dec 2025, down 65.13% year-over-year, with the annual reading at $752.9 million for FY2025, 9.84% down from the prior year.
Shares Repurchased hit $35.6 million in Q2 2025 for Hologic, down from $200.0 million in the prior quarter.
In the past five years, Shares Repurchased ranged from a high of $676.8 million in Q4 2023 to a low of $100000.0 in Q3 2021.
Historically, Shares Repurchased has averaged $182.1 million across 5 years, with a median of $143.5 million in 2021.
Biggest YoY gain for Shares Repurchased was 188400.0% in 2021; the steepest drop was 99.9% in 2021.
Year by year, Shares Repurchased stood at $167.0 million in 2021, then plummeted by 40.12% to $100.0 million in 2022, then soared by 576.8% to $676.8 million in 2023, then decreased by 23.57% to $517.3 million in 2024, then crashed by 93.12% to $35.6 million in 2025.
Business Quant data shows Shares Repurchased for HOLX at $35.6 million in Q2 2025, $200.0 million in Q1 2025, and $517.3 million in Q4 2024.